Efficacy Study on Quality of Life Criteria of a Digital Application on Any Cellphone (OnKO-Tips&Tricks) for Adolescents and Young Adults Diagnosed With Cancer

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Apr 21, 2022

Keywords

ClinConnect Summary

The clinical trial titled "Efficacy Study on Quality of Life Criteria of a Digital Application on Any Cellphone (OnKO-Tips&Tricks)" is exploring how a mobile app can help improve the quality of life for adolescents and young adults (ages 15-25) diagnosed with cancer. The app is designed to support these young patients and their families by providing useful information and resources as they navigate their treatment journey. The study will compare two groups of patients—those who use the app and those who do not—over a period of six months to see if the app leads to improvements in their well-being and helps them feel more involved in their care.

To participate in this trial, individuals must be between 15 and 25 years old and have been diagnosed with a type of cancer within the last month or have had a relapse of cancer after being treated over five years ago. Participants should be able to use a cellphone to download the app and must agree to stay in the study for 12 months, completing various questionnaires along the way. This research is important because it aims to provide tailored support for young cancer patients, helping them gain independence and actively participate in their treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient age ≥ 15 years and ≤ 25 years
• • Diagnosed with solid or blood cancers less than 1 month old or patient with relapsed cancer more than 5 years after completion of initial treatment
• • Follow-up at one of the participating study centers
• • Informed and signed consent from the patient and, if the subject is a minor, from the holders of parental authority
• • Inclusion in the study at the latest at the time of initiation of chemotherapy or radiotherapy
• • Patient agrees to 12-month post-inclusion follow-up
• • Patient agreeing to complete all study questionnaires
• • Patient with a cellphone capable of downloading the app (developed for all types of cellphones)
• • Affiliated to a social health insurance plan
• Exclusion Criteria:
• • Patient deprived of liberty by a judicial or administrative decision
• • Patient with protected person status
• • Patient who does not understand, speak or write French
• • Patient unable to understand the follow-up protocol according to the investigating physician or the IDEC of the AJA unit
• • Patient with a scheduled hospitalization of at least 5 weeks during study participation